AD

Adam D'Augelli

Early Stage Venture Capital at True Ventures

Miami, Florida

Invests in

Stages:

  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Work Experience

  • Partner

    2010

    Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups. With $3.6 billion under management, True provides pre-seed, seed, and early Series A funding to the most talented entrepreneurs in today’s fastest growing markets. Led True's investments in Ginger, Splice, Pendulum Therapeutics, Deep Genomics, Prime Roots, Flipside Crypto, Ampleforth, Forta Network, InterVenn Biosciences, Deduce, Our Kettle, Fork N Good, Nine Realms, ApeWorx, Valory, Sanctum, Radiant Graph, Dinamo Bio, LNRZ, and others currently in stealth Prior investments include: HashiCorp (NASDAQ: HCP), TripleLift (Acquired by Vista Equity), Ring (Acquired by Amazon), Runscope (Acquired by CA Technologies), Moleculo (Acquired by Illumina)

2007 - 2010

  • Instructor

    2007 - 2010

    From the Spring of 2007 until the Spring of 2010, I was a Teacher's Assistant for Introduction to Business Finance (FIN 3403) under Professor T. Craig Tapley. In the Spring of 2010, I developed the curriculum for and taught Digital Frontiers (IDH 3931), which discussed how the Internet and globalization are affecting the business world. The course was built around a series of guest lectures by speakers from local venture-backed startups and case studies developed by the students in groups.